Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018 – GuruFocus.com
Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018 GuruFocus.comBellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation …